Leonardus H.t. van der Ploeg, Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 200 shares at $30.00 ($6K) on 2019-01-16, disclosed to the SEC on 2019-01-18.
Scheduled sale ($6k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RYTM | SELL | 2018-11-06 | $1.1M | — | Filing → |
| RYTM | SELL | 2018-09-27 | $1.9M | — | Filing → |